Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Non-Current Assets (2016 - 2025)

National Healthcare (NHC) has disclosed Non-Current Assets for 16 consecutive years, with $1.1 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets fell 3.22% year-over-year to $1.1 billion, compared with a TTM value of $4.3 billion through Dec 2025, up 8.1%, and an annual FY2025 reading of $1.1 billion, down 3.22% over the prior year.
  • Non-Current Assets was $1.1 billion for Q4 2025 at National Healthcare, down from $1.1 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.1 billion in Q3 2024 and bottomed at $890.7 million in Q1 2021.
  • Average Non-Current Assets over 5 years is $982.1 million, with a median of $964.3 million recorded in 2022.
  • Peak annual rise in Non-Current Assets hit 7983.74% in 2021, while the deepest fall reached 6.21% in 2021.
  • Year by year, Non-Current Assets stood at $976.8 million in 2021, then decreased by 5.66% to $921.5 million in 2022, then decreased by 1.84% to $904.6 million in 2023, then increased by 21.61% to $1.1 billion in 2024, then decreased by 3.22% to $1.1 billion in 2025.
  • Business Quant data shows Non-Current Assets for NHC at $1.1 billion in Q4 2025, $1.1 billion in Q3 2025, and $1.1 billion in Q2 2025.